PATENT CLAIM ANALYSIS

Application Number: 15948359
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "167000"]

Abstract:
Disclosed is a compound of Formula (I) in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , X, and a are defined herein, or a pharmaceutically acceptable salt thereof. Also disclosed are a pharmaceutical composition comprising a compound or salt thereof of Formula (I) and a method of treating a disease which benefits from the modulation of the vitamin D receptor, such as a bone disorder, cardiovascular disease, a cardiovascular complication associated with renal disease, endothelial dysfunction, hyperparathyroidism, hypocalcemia, an immune disorder, left ventricular hypertrophy, a proliferative disease, proteinuria, renal disease, and thrombosis.

Claim (Index 13):
A pharmaceutical composition comprising (i) a compound or a pharmaceutically acceptable salt thereof of  claim 1  and (ii) a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 91.0
- Lexical Diversity: 1.86364
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13521980', '15537292', '13404958', '13102705', '11404267']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7235063980484249
- 35 USC 102 Novelty (BERT): 0.5081561542607202
- Combined Prediction Score: 0.7019713736696545
- Mean Citation Score: 257.772788
- Max Citation Score: 264.4791
- Similarity Product: 199.24943381795885

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test